SAGARD PRIVATE EQUITY PARTNERS of PARIS is an SEC exempt reporting adviser (CRD 162504).
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Gregory James Fleming | TRUSTEE | Redwood City, CA |
| Paul Guy Desmarais | TRUSTEE | — |
| Sophie Caroline Desmarais | TRUSTEE, NON-VOTING | — |
| Gary Albert Doer | TRUSTEE | — |
| Andre Roger Desmarais | TRUSTEE | — |
| Jocelyn Lefebvre | CEO/CCO | — |
| Antoine Ernoult-Dairaine | MANAGING DIRECTOR | — |
| Jeremy Boulle | CHIEF COMPLIANCE OFFICER | — |
| Catherine Molly-Mitton | CHIEF LEGAL OFFICER; GENERAL SECRETARY | — |
| Romain Plouzeau | CHIEF FINANCIAL OFFICER | — |
| Nicolas De Salmon De Loiray | MANAGING DIRECTOR/CHIEF OPERATIONS OFFICER | — |
| FLEMING GREGORY JAMES | TRUSTEE | — |
| DESMARAIS PAUL GUY | SHAREHOLDER DIRECTOR; TRUSTEE | — |
| DESMARAIS JACQUELINE | TRUSTEE | — |
| PLESSIS-BELAIR MICHEL | TRUSTEE | — |
| FORTIN GUY | TRUSTEE | — |
| DESMARAIS PAUL | TRUSTEE | — |
| DESMARAIS ANDRE | TRUSTEE | — |
| DESMARAIS ANDRE ROGER | TRUSTEE | — |
| DESMARAIS SOPHIE | TRUSTEE | — |
| Desmarais Sophie Caroline | TRUSTEE, NON-VOTING | — |
| DOER GARY ALBERT | TRUSTEE | — |
| LE BOURDIEC MARIANNE | CFO; GENERAL SECRETARY; MANAGING DIRECTOR | — |
| STOLAR FREDERIC | COO | — |
| LEFEBVRE JOCELYN | CEO/CCO | — |
| Fund | Type | Formed | Owners | Gross asset value | Min investment |
|---|---|---|---|---|---|
| SAGARD 4A FPCI | Private Equity Fund | France | 105 | $1.0B | $294K |
| SAGARD NEWGEN FPCI | Private Equity Fund | France | 112 | $518.6M | $118K |
| SAGARD 3 FPCI | Private Equity Fund | France | 70 | $329.4M | $1.2M |
| SAGARD MINORITY EXTENDED PARTICIPATION FUND 1 S.L.P. | Private Equity Fund | France | 41 | $290.1M | $3.5M |
| SAGARD MINORITY EXTENDED PARTICIPATION FUND 4 | Private Equity Fund | France | 41 | $226.0M | $11.8M |
| SAGARD 4B FIPS | Private Equity Fund | France | 105 | $168.1M | $294K |
| SAGARD TESTING FPCI | Private Equity Fund | France | 12 | $73.1M | $5.9M |
| SAGARD II-A FPCI | Private Equity Fund | France | 65 | $23.5M | $35.3M |
| SAGARD NEWGEN PHARMA FPCI | Private Equity Fund | France | 7 | $20.0M | $6.2M |
| SAGARD II-B FPCI | Private Equity Fund | France | 49 | $5.9M | $35.3M |